Cargando…
Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs
A Cox proportional hazard (CoxPH) model is conventionally used to assess exposure–response (E–R), but its performance to uncover the ground truth when only one dose level of data is available has not been systematically evaluated. We established a simulation workflow to generate realistic E–R datase...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662202/ https://www.ncbi.nlm.nih.gov/pubmed/35988264 http://dx.doi.org/10.1002/psp4.12859 |
_version_ | 1784830642009145344 |
---|---|
author | Poon, Victor Lu, Dan |
author_facet | Poon, Victor Lu, Dan |
author_sort | Poon, Victor |
collection | PubMed |
description | A Cox proportional hazard (CoxPH) model is conventionally used to assess exposure–response (E–R), but its performance to uncover the ground truth when only one dose level of data is available has not been systematically evaluated. We established a simulation workflow to generate realistic E–R datasets to assess the performance of the CoxPH model in recovering the E–R ground truth in various scenarios, considering two potential reasons for the confounded E–R relationship. We found that at high doses, when the pharmacological effects are largely saturated, missing important confounders is the major reason for inferring false‐positive E–R relationships. At low doses, when a positive E–R slope is the ground truth, either missing important confounders or mis‐specifying the interactions can lead to inaccurate estimates of the E–R slope. This work constructed a simulation workflow generally applicable to clinical datasets to generate clinically relevant simulations and provide an in‐depth interpretation on the E–R relationships with confounders inferred by the conventional CoxPH model. |
format | Online Article Text |
id | pubmed-9662202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96622022022-11-14 Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs Poon, Victor Lu, Dan CPT Pharmacometrics Syst Pharmacol Research A Cox proportional hazard (CoxPH) model is conventionally used to assess exposure–response (E–R), but its performance to uncover the ground truth when only one dose level of data is available has not been systematically evaluated. We established a simulation workflow to generate realistic E–R datasets to assess the performance of the CoxPH model in recovering the E–R ground truth in various scenarios, considering two potential reasons for the confounded E–R relationship. We found that at high doses, when the pharmacological effects are largely saturated, missing important confounders is the major reason for inferring false‐positive E–R relationships. At low doses, when a positive E–R slope is the ground truth, either missing important confounders or mis‐specifying the interactions can lead to inaccurate estimates of the E–R slope. This work constructed a simulation workflow generally applicable to clinical datasets to generate clinically relevant simulations and provide an in‐depth interpretation on the E–R relationships with confounders inferred by the conventional CoxPH model. John Wiley and Sons Inc. 2022-09-16 2022-11 /pmc/articles/PMC9662202/ /pubmed/35988264 http://dx.doi.org/10.1002/psp4.12859 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Poon, Victor Lu, Dan Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title | Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title_full | Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title_fullStr | Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title_full_unstemmed | Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title_short | Performance of Cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
title_sort | performance of cox proportional hazard models on recovering the ground truth of confounded exposure–response relationships for large‐molecule oncology drugs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662202/ https://www.ncbi.nlm.nih.gov/pubmed/35988264 http://dx.doi.org/10.1002/psp4.12859 |
work_keys_str_mv | AT poonvictor performanceofcoxproportionalhazardmodelsonrecoveringthegroundtruthofconfoundedexposureresponserelationshipsforlargemoleculeoncologydrugs AT ludan performanceofcoxproportionalhazardmodelsonrecoveringthegroundtruthofconfoundedexposureresponserelationshipsforlargemoleculeoncologydrugs |